Ms. Sunisa Yoodee, PhD, a Level 1 Researcher at the Medical Proteomics Unit, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, participated in the 2026 American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting held in Washington, DC, USA, from March 7–10, 2026.

Ms. Yoodee presented her research through a poster presentation entitled “GDP-L-fucose synthase is a novel modulator of calcium oxalate kidney stone-forming processes”, contributing valuable insights to the field of molecular mechanisms in urological pathophysiology.

The participation in ASBMB 2026 offers significant advantages for Siriraj Hospital’s research infrastructure and clinical applications:

Methodological Advancement: Exposure to cutting-edge biochemical and molecular biology techniques will enhance the Medical Proteomics Unit’s analytical capabilities and research methodology standards.

Translational Research Opportunities: The broad scope of molecular life sciences presented at the conference provides potential pathways for translating basic research findings into clinical applications and therapeutic interventions.

Technology Integration: Updated knowledge of emerging technologies and innovative analytical approaches will strengthen the research department’s capacity for high-impact studies and grant competitiveness.

Collaborative Networks: Engagement with international researchers in biochemistry and molecular biology establishes opportunities for multi-institutional research partnerships and knowledge exchange programs.

Clinical Application: Insights gained regarding molecular pathways in disease processes can inform evidence-based treatment strategies and contribute to improved patient outcomes at Siriraj Hospital.

This international research participation underscores Siriraj Hospital’s commitment to advancing medical knowledge through rigorous scientific inquiry and maintaining its position as a leading academic medical institution.